Il-23/Th17 cell pathway: A promising target to alleviate thymic inflammation maintenance in myasthenia gravis

IL-23/Th17 pathway has been identified to sustain inflammatory condition in several autoimmune diseases and therefore being targeted in various therapeutic and effective approaches. Patients affected with autoimmune myasthenia gravis exhibit a disease effector tissue, the thymus, that harbors ectopi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of autoimmunity 2019-03, Vol.98, p.59-73
Hauptverfasser:	Villegas, José A., Bayer, Alexandra C., Ider, Katia, Bismuth, Jacky, Truffault, Frédérique, Roussin, Régine, Santelmo, Nicola, Le Panse, Rozen, Berrih-Aknin, Sonia, Dragin, Nadine
Format:	Artikel
Sprache:	eng
Schlagworte:	Germinal centers Immunology Interleukin 17 Interleukin 23 Life Sciences Myasthenia gravis Thymic epithelial cells
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!